CN103638557B - 一种脱抗原生物骨及其制备方法 - Google Patents
一种脱抗原生物骨及其制备方法 Download PDFInfo
- Publication number
- CN103638557B CN103638557B CN201310507012.9A CN201310507012A CN103638557B CN 103638557 B CN103638557 B CN 103638557B CN 201310507012 A CN201310507012 A CN 201310507012A CN 103638557 B CN103638557 B CN 103638557B
- Authority
- CN
- China
- Prior art keywords
- bone
- hours
- osseous granules
- purified water
- hydrogen peroxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 121
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 57
- 239000000427 antigen Substances 0.000 claims abstract description 35
- 239000011259 mixed solution Substances 0.000 claims abstract description 22
- 239000000243 solution Substances 0.000 claims abstract description 20
- 230000001954 sterilising effect Effects 0.000 claims abstract description 13
- 102000036639 antigens Human genes 0.000 claims abstract description 10
- 108091007433 antigens Proteins 0.000 claims abstract description 10
- 239000004094 surface-active agent Substances 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 6
- 239000002245 particle Substances 0.000 claims abstract description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 49
- 239000008187 granular material Substances 0.000 claims description 44
- 230000008569 process Effects 0.000 claims description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 33
- 239000008213 purified water Substances 0.000 claims description 32
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 27
- 229960002163 hydrogen peroxide Drugs 0.000 claims description 27
- 238000004140 cleaning Methods 0.000 claims description 25
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 18
- 230000007935 neutral effect Effects 0.000 claims description 15
- 230000005855 radiation Effects 0.000 claims description 10
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 claims description 9
- 239000003463 adsorbent Substances 0.000 claims description 8
- 230000008961 swelling Effects 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 7
- 238000007654 immersion Methods 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 claims description 5
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 5
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- 210000001185 bone marrow Anatomy 0.000 claims description 4
- 244000309464 bull Species 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 3
- 239000013504 Triton X-100 Substances 0.000 claims 1
- 229920004890 Triton X-100 Polymers 0.000 claims 1
- 238000011017 operating method Methods 0.000 claims 1
- 238000010298 pulverizing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 65
- 102000008186 Collagen Human genes 0.000 abstract description 18
- 108010035532 Collagen Proteins 0.000 abstract description 18
- 229920001436 collagen Polymers 0.000 abstract description 14
- 230000003544 deproteinization Effects 0.000 abstract description 14
- 102000004169 proteins and genes Human genes 0.000 abstract description 14
- 108090000623 proteins and genes Proteins 0.000 abstract description 14
- 229910052588 hydroxylapatite Inorganic materials 0.000 abstract description 9
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 abstract description 9
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 abstract description 8
- 239000013078 crystal Substances 0.000 abstract description 6
- 239000005416 organic matter Substances 0.000 abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 5
- 238000004132 cross linking Methods 0.000 abstract description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract description 3
- 210000000963 osteoblast Anatomy 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 2
- 230000011164 ossification Effects 0.000 abstract description 2
- 238000002425 crystallisation Methods 0.000 abstract 2
- 230000008025 crystallization Effects 0.000 abstract 2
- 201000003101 Coloboma Diseases 0.000 abstract 1
- 238000001179 sorption measurement Methods 0.000 abstract 1
- 230000007547 defect Effects 0.000 description 10
- 230000000890 antigenic effect Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 238000005242 forging Methods 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000008439 repair process Effects 0.000 description 6
- 241000282894 Sus scrofa domesticus Species 0.000 description 5
- 238000001354 calcination Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000003837 high-temperature calcination Methods 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000282898 Sus scrofa Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000002138 osteoinductive effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000003462 bioceramic Substances 0.000 description 2
- 210000002449 bone cell Anatomy 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000009849 deactivation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 210000004409 osteocyte Anatomy 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical group OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 101710160107 Outer membrane protein A Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002082 fibula Anatomy 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000001981 hip bone Anatomy 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000006432 protein unfolding Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009772 tissue formation Effects 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310507012.9A CN103638557B (zh) | 2013-10-24 | 2013-10-24 | 一种脱抗原生物骨及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310507012.9A CN103638557B (zh) | 2013-10-24 | 2013-10-24 | 一种脱抗原生物骨及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103638557A CN103638557A (zh) | 2014-03-19 |
CN103638557B true CN103638557B (zh) | 2015-05-27 |
Family
ID=50243926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310507012.9A Active CN103638557B (zh) | 2013-10-24 | 2013-10-24 | 一种脱抗原生物骨及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103638557B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106421911B (zh) * | 2016-10-18 | 2019-10-25 | 宁波大学 | 一种人工再生骨的制备方法 |
CN107485730B (zh) * | 2016-12-02 | 2020-10-30 | 山西中医学院 | 一种改善生物衍生羟基磷灰石细胞相容性的方法 |
CN109432493B (zh) * | 2018-09-26 | 2021-04-06 | 四川大学 | 纳米羟基磷灰石涂层多孔钛支架及其制备方法和应用 |
CN110507855B (zh) * | 2019-09-05 | 2022-04-19 | 南京屹特博医学科技发展有限公司 | 一种用于局部支撑作用的异种肋软骨制备方法 |
CN111069149A (zh) * | 2019-12-20 | 2020-04-28 | 河北鑫康辰生物技术有限公司 | 一种医用同种骨清洗方法 |
CN112569406B (zh) * | 2020-11-20 | 2022-08-05 | 诺一迈尔(苏州)医学科技有限公司 | 一种骨修复材料及其制备方法 |
CN112587729B (zh) * | 2020-12-24 | 2023-05-09 | 陕西佰傲再生医学有限公司 | 一种骨修复材料 |
CN114848920B (zh) * | 2022-04-13 | 2023-06-06 | 南京航空航天大学 | 一种多孔块状异种骨修复材料的极短流程免煅烧制备方法 |
CN115317670B (zh) * | 2022-08-05 | 2023-11-07 | 武汉启思达科技发展有限公司 | 一种可塑型煅烧骨修复材料及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1552467A (zh) * | 2003-11-05 | 2004-12-08 | 中国人民解放军第三军医大学野战外科 | 一种异种脱细胞骨基质材料及制备方法 |
US6933103B1 (en) * | 2001-03-21 | 2005-08-23 | Brennen Medical, Inc. | Biocompatible tissue for therapeutic use and method of making same |
CN101172165A (zh) * | 2007-11-16 | 2008-05-07 | 广东冠昊生物科技有限公司 | 生物型骨修复材料 |
CN101496913A (zh) * | 2008-01-31 | 2009-08-05 | 中国人民解放军总医院 | 组织工程用软骨细胞外基质三维多孔海绵支架及其制备方法 |
-
2013
- 2013-10-24 CN CN201310507012.9A patent/CN103638557B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6933103B1 (en) * | 2001-03-21 | 2005-08-23 | Brennen Medical, Inc. | Biocompatible tissue for therapeutic use and method of making same |
CN1552467A (zh) * | 2003-11-05 | 2004-12-08 | 中国人民解放军第三军医大学野战外科 | 一种异种脱细胞骨基质材料及制备方法 |
CN101172165A (zh) * | 2007-11-16 | 2008-05-07 | 广东冠昊生物科技有限公司 | 生物型骨修复材料 |
CN101496913A (zh) * | 2008-01-31 | 2009-08-05 | 中国人民解放军总医院 | 组织工程用软骨细胞外基质三维多孔海绵支架及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103638557A (zh) | 2014-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103638557B (zh) | 一种脱抗原生物骨及其制备方法 | |
JP6621539B2 (ja) | 脱細胞化生体組織マトリクス材料に基づいた骨修復のための複合材料およびそれを調製する方法 | |
US5507813A (en) | Shaped materials derived from elongate bone particles | |
US9114191B2 (en) | Process for demineralization of bone matrix with preservation of natural growth factors | |
ES2224737T3 (es) | Injerto de hueso hecho de particulas oseas. | |
JP5399264B2 (ja) | 骨成長粒子及びそれの骨誘導組成物 | |
JP5232020B2 (ja) | 石灰化ゼラチンに由来する骨移植材 | |
CN1973910B (zh) | 一种组织工程骨 | |
RU2665962C1 (ru) | Биорезорбируемый биологический матрикс для замещения дефектов костной ткани и способ его получения | |
EP1283693A1 (en) | Partially demineralized cortical bone constructs | |
CN109529119A (zh) | 一种生物型骨修复材料及其制备方法 | |
CN112203702A (zh) | 富含脱细胞化骨细胞外基质水凝胶的脱细胞化骨生物材料 | |
Safdari et al. | Recent advancements in decellularized matrix technology for bone tissue engineering | |
Karalashvili et al. | Decellularized bovine bone graft for zygomatic bone reconstruction | |
CN113694254A (zh) | 骨修复材料及骨修复材料的制备方法、应用 | |
CN1230209C (zh) | 一种异种脱细胞骨基质材料及制备方法 | |
EP2236544A1 (en) | Collagen Implant | |
Zhang et al. | In vitro and in vivo evaluation of xenogeneic bone putty with the carrier of hydrogel derived from demineralized bone matrix | |
CN103623464A (zh) | 一种自体颅骨回植技术的制备方法 | |
Hassanzadeh Nemati et al. | Comparison of SDS and TritonX-100 effects on cell removing of bovine spongy bone for using in bone replacements | |
CN114984327B (zh) | 一种复合骨缺损填补剂及其制备方法 | |
PL232494B1 (pl) | Sposób otrzymywania przeszczepu gruzu korowo-gąbczastego do regeneracji tkanki kostnej, oraz przeszczep do tej regeneracji | |
PL232501B1 (pl) | Sposób otrzymywania przeszczepu do regeneracji tkanki kostnej, zwłaszcza ludzkiej oraz przeszczep do regeneracji tkanki kostnej, zwłaszcza ludzkiej | |
CN102133426A (zh) | 仿松质骨生物活性人工骨及其制备方法 | |
CN110960731A (zh) | 一种医用外科生物补片的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Antigen-removing biological bone and preparation method thereof Effective date of registration: 20170207 Granted publication date: 20150527 Pledgee: Xianyang financing guarantee Limited by Share Ltd Pledgor: Shaanxi Boao Regeneration Medical Co., Ltd. Registration number: 2017990000090 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170531 Granted publication date: 20150527 Pledgee: Xianyang financing guarantee Limited by Share Ltd Pledgor: Shaanxi Boao Regeneration Medical Co., Ltd. Registration number: 2017990000090 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Antigen-removing biological bone and preparation method thereof Effective date of registration: 20180813 Granted publication date: 20150527 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: Shaanxi Boao Regeneration Medical Co., Ltd. Registration number: 2018610000126 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190719 Granted publication date: 20150527 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: Shaanxi Boao Regeneration Medical Co., Ltd. Registration number: 2018610000126 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Antigen-removing biological bone and preparation method thereof Effective date of registration: 20190809 Granted publication date: 20150527 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: Shaanxi Boao Regeneration Medical Co., Ltd. Registration number: Y2019980000030 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20201030 Granted publication date: 20150527 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: SHAANXI BIO REGENERATION MEDICINE Co.,Ltd. Registration number: Y2019980000030 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: An antigen-free biological bone and its preparation method Effective date of registration: 20201104 Granted publication date: 20150527 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: SHAANXI BIO REGENERATION MEDICINE Co.,Ltd. Registration number: Y2020980007532 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20211125 Granted publication date: 20150527 Pledgee: Xianyang corporate finance Company limited by guarantee Pledgor: SHAANXI BIO REGENERATIVE MEDICINE Co.,Ltd. Registration number: Y2020980007532 |